Innovative drug approvals
STO-REC-STATC8F9C5T1 Official
48
China · 2024
Innovative drug approvals in China stood at 48 in 2024 (State Council).
- Publisher
- State Council
- Authority tier
- T1 Official
- Locator
- 大力支持产业创新
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
国家药监局统计显示,2024年累计批准上市创新药48个、创新医疗器械65个。
Verbatim extraction verified: The figure 48 is directly attested in the quoted passage (大力支持产业创新).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- State Council of China. (2024). 全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网. Retrieved September 17, 2026, from https://www.gov.cn/zhengce/202501/content_6997982.htm. Via StatOrigin, https://statorigin.org/stat/stat_C8F9C5Q0MY85N20BPY0TA0T7SQ
- MLA
- State Council of China. "全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网." 2024, https://www.gov.cn/zhengce/202501/content_6997982.htm. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_C8F9C5Q0MY85N20BPY0TA0T7SQ.
- Chicago
- State Council of China. "全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网." 2024. https://www.gov.cn/zhengce/202501/content_6997982.htm. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_C8F9C5Q0MY85N20BPY0TA0T7SQ.
- BibTeX
- @misc{statecouncil2024innovativea0t7sq, author = {{State Council of China}}, title = {全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市\_政策解读\_中国政府网}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_C8F9C5Q0MY85N20BPY0TA0T7SQ}, note = {Original source: https://www.gov.cn/zhengce/202501/content\_6997982.htm. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- State Council of China · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- 全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网
- Type
- Press release
- Published
- —
- Locator
- 大力支持产业创新
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_C8F9C5Q0MY85N20BPY0TA0T7SQ